Investor’s Alert: Inovio Pharmaceuticals (NYSEMKT:INO), Synta Pharmaceuticals (NASDAQ:SNTA), Repligen Corporation (NASDAQ:RGEN), Agios Pharmaceuticals (NASDAQ:AGIO)

Inovio Pharmaceuticals Inc (NYSE:INO) CEO Jong Joseph Kim bought 25,000 shares of the company’s stock in a transaction dated Tuesday, April 15th. The shares were purchased at an average price of $2.25 per share, for a total transaction of $56,250.00. Inovio Pharmaceuticals Inc (NYSEMKT:INO) stock performance was -2.62% in last session and finished the day at $2.60. Traded volume was 16.17million shares in the last … Continue reading Investor’s Alert: Inovio Pharmaceuticals (NYSEMKT:INO), Synta Pharmaceuticals (NASDAQ:SNTA), Repligen Corporation (NASDAQ:RGEN), Agios Pharmaceuticals (NASDAQ:AGIO)

Biotech Volatile Stocks: PTC Therapeutics (NASDAQ:PTCT), Agios Pharmaceuticals Inc (NASDAQ:AGIO), BioCryst Pharmaceuticals (NASDAQ:BCRX), TG Therapeutics (NASDAQ:TGTX)

PTC Therapeutics, Inc. (NASDAQ:PTCT) announced a corporate update and reported its financial results for the fourth quarter and full-year ended December 31, 2013. In April 2013, PTC Therapeutics, Inc. (NASDAQ:PTCT) initiated the confirmatory Phase 3 ACT DMD (Ataluren Confirmatory Trial in DMD) clinical trial evaluating ataluren as a potential treatment for patients with nonsense mutation Duchenne muscular dystrophy (nmDMD). PTC Therapeutics, Inc. (NASDAQ:PTCT) stock performance … Continue reading Biotech Volatile Stocks: PTC Therapeutics (NASDAQ:PTCT), Agios Pharmaceuticals Inc (NASDAQ:AGIO), BioCryst Pharmaceuticals (NASDAQ:BCRX), TG Therapeutics (NASDAQ:TGTX)

Agios Pharmaceuticals (NASDAQ:AGIO) was downgraded by Zacks from a “neutral” rating to an “underperform” rating in a research report issued to clients and investors on Monday, Analyst Ratings News reports. Agios Pharmaceuticals Inc (NASDAQ:AGIO) stock performance was 2.84% in last session and finished the day at $46.74. Traded volume was 983,271 million shares in the last session and the average volume of the stock remained … Continue reading Biotech Unusual Volume: Agios Pharmaceuticals (NASDAQ:AGIO), OHR (NASDAQ:OHRP), La Jolla (NASDAQ:LJPC), Aastrom Biosciences (NASDAQ:ASTM)

Agios Pharmaceuticals Inc (NASDAQ:AGIO) SVP Glenn Goddard sold 17,468 shares of the stock on the open market in a transaction that occurred on Friday, March 7th. Agios Pharmaceuticals Inc (NASDAQ:AGIO) stock performance was 13.82 % in last session and finished the day at $ 45.45. Traded volume was 1,334,731 million shares in the last session and the average volume of the stock remained 283.01 million … Continue reading Healthcare Bullish Stocks: Agios Pharmaceuticals (NASDAQ:AGIO), Rockwell Medical (NASDAQ:RMTI), OHR Pharmaceutical (NASDAQ:OHRP), Emergent Biosolutions (NYSE:EBS)

HIV usually infects blood cells through a protein on their surface, a “docking station” called CCR5. A California company, Sangamo BioSciences Inc. (NASDAQ:SGMO), makes a treatment that can knock out a gene that makes CCR5. Sangamo Biosciences, Inc. (NASDAQ:SGMO) stock performance was 17.08% in last session and finished the day at $22.96. Traded volume was 11.36 million shares in the last session and the average … Continue reading Hot Biotech Gainers: Sangamo Biosciences (NASDAQ:SGMO), CEL-SCI Corporation (NYSEMKT:CVM), Agios Pharmaceuticals (NASDAQ:AGIO), Lpath (NASDAQ:LPTN)

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) present at the Cowen and Company 34th Annual Health Care Conference at the Boston Marriott Copley Place. Agios Pharmaceuticals Inc (NASDAQ:AGIO) stock performance was -5.69% in last session and finished the day at $29.48. Traded volume was 263,884 million shares in the last session and the average volume of the stock remained 254.15 million shares. Agios Pharmaceuticals Inc (NASDAQ:AGIO) insider ownership … Continue reading Biotech Losers In News: Agios Pharmaceuticals (NASDAQ:AGIO), Cell Therapeutics (NASDAQ:CTIC), NewLink Genetics (NASDAQ:NLNK), Mirati Therapeutics (NASDAQ:MRTX)